12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • Janux Therapeutics JANX stock rose 120.5% to $33.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5 billion.
  • Viking Therapeutics VKTX shares increased by 97.24% to $75.9. The market value of their outstanding shares is at $7.6 billion.
  • TransMedics Gr TMDX stock rose 22.2% to $95.0. The company's market cap stands at $3.1 billion. As per the news, the Q4 earnings report came out yesterday.
  • Codexis CDXS shares rose 21.24% to $3.88. The market value of their outstanding shares is at $270.9 million.
  • Ligand Pharmaceuticals LGND shares moved upwards by 20.93% to $90.0. The company's market cap stands at $1.5 billion. The company's, Q4 earnings came out today.
  • Hims & Hers Health HIMS shares rose 19.5% to $12.25. The company's market cap stands at $2.5 billion. As per the press release, Q4 earnings came out yesterday.

Losers

  • NRX Pharmaceuticals NRXP shares decreased by 22.9% to $0.33 during Tuesday's pre-market session. The company's market cap stands at $28.0 million.
  • Veradigm MDRX shares decreased by 22.03% to $6.48. The market value of their outstanding shares is at $708.0 million.
  • Precision BioSciences DTIL shares decreased by 18.32% to $13.07. The market value of their outstanding shares is at $53.1 million.
  • HeartBeam BEAT shares fell 14.79% to $1.21. The market value of their outstanding shares is at $31.8 million.
  • MediciNova MNOV shares fell 11.54% to $1.15. The company's market cap stands at $56.4 million.
  • BioSig Technologies BSGM stock fell 10.23% to $0.43. The market value of their outstanding shares is at $4.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!